Incannex Healthcare Announces Successful Pre-IND Meeting with FDA for Opioid Use Disorder Treatment
May 7, 2024
Incannex Investment Portfolios
Incannex Healthcare Shares on the Rise Following Positive Trial Results
Feb 29, 2024
Incannex's Groundbreaking CannQuit-N Moves Forward After Positive Pre-IND Meeting with the FDA
Feb 17, 2024